SOPHiA GENETICS (SOPH) Payables (2020 - 2026)

SOPHiA GENETICS has disclosed Payables across 7 years of filings, most recently posting $11.9 million for Q2 2026.

• In Q2 2026, Payables rose 53.94% year-over-year to $11.9 million; the TTM figure through Jun 2026 stood at $11.9 million (up 53.94% YoY), while the FY2025 annual figure was $9.0 million, up 71.65% from the prior year.
• Payables came in at $11.9 million for Q2 2026 at SOPHiA GENETICS, down from $12.7 million in the prior quarter.
• In the past five years, Payables ranged from a high of $12.7 million in Q1 2026 to a low of $4.6 million in Q1 2025.
• Average Payables over 5 years is $7.1 million, with a median of $6.2 million recorded in 2022.
• Year-over-year, Payables slumped 35.93% in 2022 and jumped 175.03% in 2026.
• Over 5 years, Payables stood at $6.2 million in 2022, then retreated by 12.78% to $5.4 million in 2023, then fell by 3.17% to $5.2 million in 2024, then jumped by 71.65% to $9.0 million in 2025, then jumped by 32.86% to $11.9 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $11.9 million in Q2 2026, $12.7 million in Q1 2026, and $9.0 million in Q4 2025.